Systemic lupus erythematosus (SLE) is an inflammatory condition that can potentially affect multiple organ systems. Due to scientific medical advances, morbidity and mortality associated with SLE have improved in recent decades. However, there is still much to do regarding early recognition and optimum treatment for this condition. Teams of health professionals, including PAs, from various medical specialties will yield the best outcomes. The American College of Rheumatology is updating the treatment guidelines for lupus and lupus nephritis which are expected to be published in 2025. Recognizing health disparities and how lupus affects persons of varying ethnicity is also important. This session will provide a review and update of diagnostics, treatment, and monitoring approaches for SLE.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Outline the diagnostic criteria and differential diagnosis for systemic lupus erythematosus (SLE)
Utilize basic approaches for management of SLE including steroids, DMARDs. and biologics
Perform routine monitoring for SLE complications and comorbidities
